Regulus Therapeutics
RGLS
#8845
Rank
NZ$0.15 B
Marketcap
$2.40
Share price
0.00%
Change (1 day)
6.02%
Change (1 year)

Earnings for Regulus Therapeutics (RGLS)

Earnings in 2024 (TTM): -NZ$57.47 Million

According to Regulus Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -NZ$50.44 Million a decrease over its 2022 earnings that were of -NZ$47.36 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regulus Therapeutics from 2012 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$57.47 Million13.94%
2023 -NZ$50.44 Million6.51%
2022 -NZ$47.36 Million2.53%
2021 -NZ$46.19 Million93.59%
2020 -NZ$23.86 Million-15.41%
2019 -NZ$28.21 Million-64.46%
2018 -NZ$79.35 Million-33.26%
2017 -NZ$0.12 Billion-13.98%
2016 -NZ$0.14 Billion44.77%
2015 -NZ$95.48 Million-1.63%
2014 -NZ$97.06 Million203.6%
2013 -NZ$31.97 Million8.65%
2012 -NZ$29.43 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$7.14 B-12,017.11%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$12.69 B-21,265.86%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$2.25 B-3,854.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$16.11 B-26,963.62%๐Ÿ‡ฌ๐Ÿ‡ง UK
-NZ$0.33 Billion 433.96%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.36 Billion 489.91%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$11.79 Billion 19,557.70%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.21 Billion 236.16%๐Ÿ‡บ๐Ÿ‡ธ USA